Swiss National Bank
WVE icon

Swiss National Bank’s Wave Life Sciences WVE Stock Holding History

Swiss National Bank’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Hold
219,700
– – ﹤0.01% 1961
2025
Q4 		$3.73M Buy
219,700
+8,700
+4% +$88.4K ﹤0.01% 1522
2025
Q3 		$1.54M Buy
211,000
+5,800
+3% +$46.9K ﹤0.01% 1976
2025
Q2 		$1.33M Buy
205,200
+13,200
+7% +$87.2K ﹤0.01% 2003
2025
Q1 		$1.55M Sell
192,000
-16,800
-8% -$184K ﹤0.01% 1909
2024
Q4 		$2.58M Buy
208,800
+52,300
+33% +$698K ﹤0.01% 1712
2024
Q3 		$1.28M Hold
156,500
– – ﹤0.01% 2097
2024
Q2 		$781K Hold
156,500
– – ﹤0.01% 2280
2024
Q1 		$966K Buy
156,500
+4,100
+3% +$20.5K ﹤0.01% 2242
2023
Q4 		$770K Buy
+152,400
New +$815K ﹤0.01% 2371
2021
Q2 		– Sell
-72,500
Closed -$407K – 2653
2021
Q1 		$407K Buy
72,500
+6,100
+9% +$58.6K ﹤0.01% 2470
2020
Q4 		$523K Hold
66,400
– – ﹤0.01% 2454
2020
Q3 		$564K Buy
66,400
+20,500
+45% +$225K ﹤0.01% 2338
2020
Q2 		$478K Buy
45,900
+9,800
+27% +$92.2K ﹤0.01% 2385
2020
Q1 		$338K Hold
36,100
– – ﹤0.01% 2315
2019
Q4 		$289K Buy
36,100
+800
+2% +$19.6K ﹤0.01% 2492
2019
Q3 		$725K Buy
35,300
+1,100
+3% +$25.2K ﹤0.01% 2218
2019
Q2 		$892K Buy
34,200
+800
+2% +$22.4K ﹤0.01% 2178
2019
Q1 		$1.3M Buy
33,400
+12,700
+61% +$515K ﹤0.01% 1926
2018
Q4 		$870K Buy
20,700
+1,300
+7% +$57.8K ﹤0.01% 2082
2018
Q3 		$970K Hold
19,400
– – ﹤0.01% 2159
2018
Q2 		$742K Hold
19,400
– – ﹤0.01% 2318
2018
Q1 		$778K Buy
19,400
+1,000
+5% +$42K ﹤0.01% 2217
2017
Q4 		$646K Hold
18,400
– – ﹤0.01% 2334
2017
Q3 		$400K Hold
18,400
– – ﹤0.01% 2432
2017
Q2 		$342K Buy
18,400
+6,900
+60% +$149K ﹤0.01% 2505
2017
Q1 		$316K Hold
11,500
– – ﹤0.01% 2478
2016
Q4 		$301K Buy
+11,500
New +$374K ﹤0.01% 2518

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Swiss National Bank's WVE Position: Q1 2026 in Review

Swiss National Bank held its Wave Life Sciences (WVE) position steady in Q1 2026 at 219,700 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1961.

Swiss National Bank first reported a position in WVE in Q4 2016 and has held it in 28 quarters since. The position peaked at $3.73M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Swiss National Bank held 219,700 shares of Wave Life Sciences worth $1.59M as of Q1 2026.
  • Swiss National Bank left its Wave Life Sciences share count unchanged in Q1 2026.
  • Wave Life Sciences made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1961 holding.
  • Swiss National Bank first reported a position in Wave Life Sciences in Q4 2016 and has held it in 28 quarters since.
  • Swiss National Bank's Wave Life Sciences position peaked at $3.73M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.